Skip to main content
Log in

Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

SPECT/CT after pericervical injection of technetium-99 m-nanocolloid was shown to be suitable for sentinel lymph node (SLN) mapping in endometrial cancer (EC). The aim of this study was to analyze factors affecting successful SLN detection by means of SPECT/CT such as imaging findings, patient characteristics and tumor biology in a large cohort of patients.

Methods

One hundred and forty-five consecutive patients suffering from EC who received pre-surgical SLN mapping at our institution between 2011 and 2016 were included in this analysis. SPECT/CT data of abdomen and pelvis (mean 4:20 ± 1:20 h p.i.) were acquired after pericervical injection of technetium-99 m-nanocolloid (mean 230 ± 45 MBq) in all patients. Surgical staging was performed on the day after. Acquisition parameters, patient characteristics, SPECT/CT findings as well as histopathological results were collected.

Results

A total of 282 SLNs were identified by means of SPECT/CT. Overall, preoperative and intraoperative SLN detection rates were 86%, 76% and 74% respectively. The most important factor associated with failure to detect SLNs was the presence of high bone marrow on SPECT/CT (p = 0.005). Peritoneal/abdominal radioactivity was also associated with missed SLN detection in SPECT/CT (p = 0.02). However, the presence of liver/spleen uptake on its own was not predictive for detection failure. Low numbers of detected SLNs in SPECT/CT were slightly related with older age and lower injected activity. No significant influence was found for the parameters of tumor histology and stage, lymph node involvement and the time gap between injection and imaging.

Conclusions

Venous drainage as indicated by bone marrow uptake is the most important factor associated with scintigraphic SLN detection failure. Moreover, high peritoneal and abdominal activity was also associated with detection failure. Thus, meticulous application of the radiotracer is crucial in EC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (Oxf, Engl: 1990). 2013;49:1374–403. doi:10.1016/j.ejca.2012.12.027.

    Article  CAS  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. doi:10.3322/caac.21254.

    Article  PubMed  Google Scholar 

  3. Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. The Cochrane database of systematic reviews. 2015:CD007585. doi:10.1002/14651858.CD007585.pub3.

  4. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Frigerio L, et al. Management of endometrial cancer: issues and controversies. Eur J Gynaecol Oncol. 2016;37:6–12.

    CAS  PubMed  Google Scholar 

  5. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet (Lond, Engl). 2010;375:1165–72. doi:10.1016/s0140-6736(09)62002-x.

    Article  Google Scholar 

  6. Holloway RW, Gupta S, Stavitzski NM, Zhu X, Takimoto EL, Gubbi A, et al. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. Gynecol Oncol. 2016;141:206–10. doi:10.1016/j.ygyno.2016.02.018.

    PubMed  Google Scholar 

  7. Leitao Jr MM, Khoury-Collado F, Gardner G, Sonoda Y, Brown CL, Alektiar KM, et al. Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol. 2013;129:38–41. doi:10.1016/j.ygyno.2013.01.002.

    Article  PubMed  Google Scholar 

  8. Khoury-Collado F, St Clair C, Abu-Rustum NR. Sentinel lymph node mapping in endometrial cancer: an update. Oncologist. 2016;21:461–6. doi:10.1634/theoncologist.2015-0473.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zahl Eriksson AG, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G, et al. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol. 2016;140:394–9. doi:10.1016/j.ygyno.2015.12.028.

    Article  PubMed  Google Scholar 

  10. Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med life. 2015;8:176–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. New ASCO, SSO guidelines for sentinel lymph node biopsy in melanoma. Oncology (Williston Park, NY). 2012;26:841–2.

  12. Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol. 2011;123:522–7. doi:10.1016/j.ygyno.2011.08.034.

    Article  PubMed  Google Scholar 

  13. Ahmed M, Purushotham AD, Horgan K, Klaase JM, Douek M. Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer. Br J Surg. 2015;102:169–81. doi:10.1002/bjs.9673.

    Article  CAS  PubMed  Google Scholar 

  14. Hoogendam JP, Veldhuis WB, Hobbelink MG, Verheijen RH, van den Bosch MA, Zweemer RP. 99mTc SPECT/CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and Metaanalysis. J Nucl Med. 2015;56:675–80. doi:10.2967/jnumed.114.152439.

    Article  PubMed  Google Scholar 

  15. Buda A, Elisei F, Arosio M, Dolci C, Signorelli M, Perego P, et al. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review. Int J Gynecol Cancer. 2012;22:830–5. doi:10.1097/IGC.0b013e318253496f.

    Article  PubMed  Google Scholar 

  16. Sawicki S, Kobierski J, Lapinska-Szumczyk S, Lass P, Cytawa W, Bianek-Bodzak A, et al. Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancer. Nucl Med Commun. 2013;34:590–6. doi:10.1097/MNM.0b013e328360d8cc.

    Article  PubMed  Google Scholar 

  17. Perissinotti A, Paredes P, Vidal-Sicart S, Torne A, Albela S, Navales I, et al. Use of SPECT/CT for improved sentinel lymph node localization in endometrial cancer. Gynecol Oncol. 2013;129:42–8. doi:10.1016/j.ygyno.2013.01.022.

    Article  CAS  PubMed  Google Scholar 

  18. Mucke J, Klapdor R, Schneider M, Langer F, Gratz KF, Hillemanns P, et al. Isthmocervical labelling and SPECT/CT for optimized sentinel detection in endometrial cancer: technique, experience and results. Gynecol Oncol. 2014;134:287–92. doi:10.1016/j.ygyno.2014.05.001.

    Article  CAS  PubMed  Google Scholar 

  19. Niikura H, Kaiho-Sakuma M, Tokunaga H, Toyoshima M, Utsunomiya H, Nagase S, et al. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 2013;131:299–303. doi:10.1016/j.ygyno.2013.08.018.

    Article  PubMed  Google Scholar 

  20. Sahbai S, Taran FA, Fiz F, Staebler A, Becker S, Solomayer E, et al. Pericervical injection of 99mTc-Nanocolloid is superior to Peritumoral injection for sentinel lymph node detection of endometrial cancer in SPECT/CT. Clin Nucl Med. 2016;41:927–32. doi:10.1097/rlu.0000000000001414.

    Article  PubMed  Google Scholar 

  21. Frati A, Ballester M, Dubernard G, Bats AS, Heitz D, Mathevet P, et al. Contribution of lymphoscintigraphy for sentinel lymph node biopsy in women with early stage endometrial cancer: results of the SENTI-ENDO study. Ann Surg Oncol. 2015;22:1980–6. doi:10.1245/s10434-014-4203-7.

    Article  CAS  PubMed  Google Scholar 

  22. Dittmann H, Becker S, Bares R. Detection of sentinel lymph nodes after hysteroscopic peritumoral injection of Tc-99m-Nanocolloid in grade 1 endometrial carcinoma. J Nucl Med. 2010;51:18.

    Article  Google Scholar 

  23. Eldweny H, Alkhaldy K, Alsaleh N, Abdulsamad M, Abbas A, Hamad A, et al. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (pilot study). J Egypt Natl Cancer Inst. 2012;24:23–30. doi:10.1016/j.jnci.2011.12.004.

    Article  Google Scholar 

  24. Coufal O, Zapletal O, Vrtelova P, Vasina J, Rehak Z. Failed preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer, possible causes and implications for the surgery - the analysis of 3014 procedures. Rozhl Chir. 2015;94:126–30.

    CAS  PubMed  Google Scholar 

  25. Bernardi S, Bertozzi S, Londero AP, Angione V, Petri R, Giacomuzzi F. Prevalence and risk factors of intraoperative identification failure of sentinel lymph nodes in patients affected by breast cancer. Nucl Med Commun. 2013;34:664–73. doi:10.1097/MNM.0b013e328361cd84.

    Article  PubMed  Google Scholar 

  26. Klingensmith 3rd WC, Spitzer VM, Fritzberg AR, Kuni CC. Normal appearance and reproducibility of liver-spleen studies with Tc-99m sulfur colloid and Tc-99m microalbumin colloid. J Nucl Med. 1983;24:8–13.

    CAS  PubMed  Google Scholar 

  27. Dordea M, Colvin H, Cox P, Pujol Nicolas A, Kanakala V, Iwuchukwu O. Clinical and histopathological factors affecting failed sentinel node localization in axillary staging for breast cancer. Surgeon. 2013;11:63–6. doi:10.1016/j.surge.2011.10.006.

    Article  PubMed  Google Scholar 

  28. Birdwell RL, Smith KL, Betts BJ, Ikeda DM, Strauss HW, Jeffrey SS. Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology. 2001;220:47–53. doi:10.1148/radiology.220.1.r01jn2347.

    Article  CAS  PubMed  Google Scholar 

  29. Wuntakal R, Papadopoulos AJ, Montalto SA, Perovic M, Coutts M, Devaja O. Location of sentinel lymph node in cervical carcinoma and factors associated with unilateral detection. Int J Gynecol Cancer. 2015;25:1663–8. doi:10.1097/igc.0000000000000539.

    Article  PubMed  Google Scholar 

  30. Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C. Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging. 2008;35:32–8. doi:10.1007/s00259-007-0516-0.

    Article  PubMed  Google Scholar 

  31. Wengenmair H, Kopp J, Vogt H, Wawroschek F, Grober S, Dorn R, et al. Sentinel lymph node diagnosis in prostatic carcinoma: II. Biokinetics and dosimetry of 99mTc-Nanocolloid after intraprostatic injection. Nuklearmedizin. 2002;41:102–7.

    CAS  PubMed  Google Scholar 

  32. Soares MM, Keramida G, Glass DM, Mortimer PS, Peters AM. Lymph proteins may access peripheral blood without entering thoracic duct in patients with lymphatic dysfunction. J Vasc Surg Venous Lymphat Disord. 2016;4:215–20. doi:10.1016/j.jvsv.2015.10.010.

    Article  PubMed  Google Scholar 

  33. Stamp GF, Peters AM. Peripheral lymphovenous communication in lymphoedema. Nucl Med Commun. 2012;33:701–7. doi:10.1097/MNM.0b013e32835313d4.

    Article  PubMed  Google Scholar 

  34. Kalin B, Axelsson B, Jacobsson H. Quantitative evaluation of four 99Tcm colloids for bone marrow scintigraphy using single photon emission computed tomography. Nucl Med Commun. 1991;12:135–45.

    Article  CAS  PubMed  Google Scholar 

  35. Soran A, Falk J, Bonaventura M, Keenan D, Ahrendt G, Johnson R. Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity? J Am Coll Surg. 205:66–71. doi:10.1016/j.jamcollsurg.2007.01.064.

  36. Sener SF, Winchester DJ, Brinkmann E, Winchester DP, Alwawi E, Nickolov A, et al. Failure of sentinel lymph node mapping in patients with breast cancer. J Am Coll Surg. 2004;198:732–6. doi:10.1016/j.jamcollsurg.2004.01.006.

    Article  PubMed  Google Scholar 

  37. Rubello D, Zavagno G, Bozza F, Lise M, De Salvo GL, Saladini G, et al. Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin. Nucl Med Commun. 2004;25:1119–24.

    Article  PubMed  Google Scholar 

  38. Bats AS, Frati A, Mathevet P, Orliaguet I, Querleu D, Zerdoud S, et al. Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer: analysis of the prospective multicenter SENTICOL cohort. Gynecol Oncol. 2015;137:264–9. doi:10.1016/j.ygyno.2015.02.018.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samine Sahbai.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahbai, S., Taran, FA., Staebler, A. et al. Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate. Eur J Nucl Med Mol Imaging 44, 1511–1519 (2017). https://doi.org/10.1007/s00259-017-3692-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-017-3692-6

Keywords

Navigation